MUC1 Aptamer-Based Near-Infrared Fluorescence Probes for Tumor Imaging

Molecular Imaging and Biology

Volumn 17, Issue 1, 2015, Pages 38-48

  Chen, Haiyan ^a   Zhao, Juan ^a   Zhang, Min ^a   Yang, Haibo ^a   Ma, Yuxiang ^a   Gu, Yueqing ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

MUC1 aptamer; Near infrared fluorescence; PEG; Tumor imaging; Tumor targeting

Indexed keywords

APTAMER; FLUORESCENT DYE; MACROGOL DERIVATIVE; MUC1 PROTEIN, HUMAN; MUCIN 1;

ANIMAL; CHEMISTRY; CONFOCAL MICROSCOPY; HEPG2 CELL LINE; HUMAN; MCF 7 CELL LINE; MOUSE; NEAR INFRARED SPECTROSCOPY; NEOPLASMS; NUDE MOUSE; PATHOLOGY; THIN LAYER CHROMATOGRAPHY; TUMOR CELL LINE; ULTRAVIOLET SPECTROPHOTOMETRY;

ANIMALS; APTAMERS, NUCLEOTIDE; CELL LINE, TUMOR; CHROMATOGRAPHY, THIN LAYER; FLUORESCENT DYES; HEP G2 CELLS; HUMANS; MCF-7 CELLS; MICE; MICE, NUDE; MICROSCOPY, CONFOCAL; MUCIN-1; NEOPLASMS; POLYETHYLENE GLYCOLS; SPECTROPHOTOMETRY, ULTRAVIOLET; SPECTROSCOPY, NEAR-INFRARED;

EID: 84938321775     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-014-0763-y     Document Type: Article

References (29)

1. Mukhopadhyay P, Chakraborty S, Ponnusamy MP et al (2011) Mucins in the pathogenesis of breast cancer: implications in diagnosis, prognosis and therapy. Biochim Biophys Acta 1815:224–240
2. Dasanu CA, Sethi N, Ahmed N (2012) Immune alterations and emerging immunotherapeutic approaches in lung cancer. Expert Opin Biol Ther 12:923–937
3. Bafna S, Kaur S, Batra SK (2010) Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells. Oncogene 29:2893–2904
4. Pillai K, Pourgholami MH, Chua TC, Morris DL (2013) MUC1 as a potential target in anticancer therapies. Am J Clin Oncol. doi:10.1097/COC. 0b013e31828f5a07
5. Cao Y, Karsten U (2001) Binding patterns of 51 monoclonal antibodies to peptide and carbohydrate epitopes of the epithelial mucin (MUC1) on tissue sections of adenolymphomas of the parotid (Warthin’s tumours): role of epitope masking by glycans. Histochem Cell Biol 115:349–356
6. 2 fragments as radioimmunoscintigraphy agents for breast cancer imaging. Ann Nucl Med 25:87–92
7. Seuma J, Bunch J, Cox A et al (2008) Combination of immunohistochemistry and laser ablation ICP mass spectrometry for imaging of cancer biomarkers. Proteomics 8:3775–3784
8. Lee JF, Stovall GM, Ellington AD (2006) Aptamer therapeutics advance. Curr Opin Chem Biol 10:282–289
9. Bouchard PR, Hutabarat RM, Thompson KM (2010) Discovery and development of therapeutic aptamers. Annu Rev Pharmacol Toxicol 50:237–257
10. Germer K, Leonard M, Zhang X (2013) RNA aptamers and their therapeutic and diagnostic applications. Int J Biochem Mol Biol 4:27–40
11. Hu M, Zhang K (2013) The application of aptamers in cancer research: an up-to-date review. Future Oncol 9:369–376
12. Kim JK, Choi KJ, Lee M et al (2012) Molecular imaging of a cancer-targeting theragnostics probe using a nucleolin aptamer- and microRNA-221 molecular beacon-conjugated nanoparticle. Biomaterials 33:207–217
13. Savla R, Taratula O, Garbuzenko O et al (2011) Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer. J Control Release 153:16–22
14. Ghoroghchian PP, Therien MJ, Hammer DA (2009) In vivo fluorescence imaging: a personal perspective. Wiley Interdiscip Rev Nanomed Nanobiotechnol 1:156–167
15. Luo S, Zhang E, Su Y et al (2011) A review of NIR dyes in cancer targeting and imaging. Biomaterials 32:7127–7138
16. Shan L, Xue J, Guo J et al (2011) Improved targeting of ligand-modified adenovirus as a new near infrared fluorescence tumor imaging probe. Bioconjug Chem 22:567–581
17. Guo J, Du C, Shan L (2012) Comparison of near-infrared fluorescent deoxyglucose probes with different dyes for tumor diagnosis in vivo. Contrast Media Mol Imaging 7:289–301
18. Chen H, Li B, Wang C et al (2013) Characterization of a fluorescence probe based on gold nanoclusters for cell and animal imaging. Nanotechnology 24:055704–055713
19. Liu F, Deng D, Chen F et al (2010) Folate-polyethylene glycol conjugated near-infrared fluorescence probe with high targeting affinity and sensitivity for in vivo early tumor diagnosis. Mol Imaging Biol 12:595–607
20. Mahounga DM, Shan L, Jie C (2012) Synthesis of a novel L-methyl-methionine-MPA fluorescent probe for in vivo near infrared imaging of tumors. Mol Imaging Biol 14:699–707
21. Ferreira CS, Matthews CS, Missailidis S et al (2006) DNA aptamers that bind to MUC1 tumour marker: design and characterization of MUC1-binding single-stranded DNA aptamers. Tumour Biol 27:289–301
22. Devine PL, Birrell GW, Whitehead RH et al (1992) Expression of MUC1 and MUC2 mucins by human tumor cell lines. Tumor Biology 13:268–277
23. Croce MV, Colussi AG, Price MR et al (1999) Identification and characterization of different subpopulations in a human lung adenocarcinoma cell line (A549). Pathol Oncol Res 5:197–204
24. Gursahani H, Riggs-Sauthier J, Pfeiffer J et al (2009) Absorption of polyethylene glycol (PEG) polymers: the effect of PEG size on permeability. J Pharm Sci 98:2847–2856
25. Trujillo CA, Nery AA, Alves JM et al (2007) Development of the anti-VEGF aptamer to a therapeutic agent for clinical ophthalmology. Clin Ophthalmol 1:393–402
26. Hicke BJ, Stephens AW, Gould T et al (2006) Tumor targeting by an aptamer. J Nucl Med 47:668–678
27. Ko HY, Choi KJ, Lee CH, Kim S (2011) A multimodal nanoparticle-based cancer imaging probe simultaneously targeting nucleolin, integrin αvβ3 and tenascin-C proteins. Biomaterials 32:1130–1138
28. Kim D, Jeong YY, Jon S (2010) A drug-loaded aptamer-gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer. ACS Nano 4:3689–3696
29. Wang T, Ray J (2012) Aptamer-based molecular imaging. Protein Cell 3:739–754